The combined ratio of Aß42 and Tau in the cerebrospinal fluid (CSF) has been shown to predict AD neuropathology with higher accuracy relative to the performance of these proteins individually, suggesting that both amyloid and Tau likely contribute, independently, to disease pathogenesis29. The gene discussed is MAPT; the disease is Alzheimer disease.